BR112013018938A2 - agente antifúngico tópico - Google Patents
agente antifúngico tópicoInfo
- Publication number
- BR112013018938A2 BR112013018938A2 BR112013018938A BR112013018938A BR112013018938A2 BR 112013018938 A2 BR112013018938 A2 BR 112013018938A2 BR 112013018938 A BR112013018938 A BR 112013018938A BR 112013018938 A BR112013018938 A BR 112013018938A BR 112013018938 A2 BR112013018938 A2 BR 112013018938A2
- Authority
- BR
- Brazil
- Prior art keywords
- antifungal agent
- topical antifungal
- agent
- topical
- pyrazol
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title abstract 2
- 239000003429 antifungal agent Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- BMTGLHWYLKPGMY-UHFFFAOYSA-N 2-pyrazol-1-ylphenol Chemical compound OC1=CC=CC=C1N1N=CC=C1 BMTGLHWYLKPGMY-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002160 anti-trichophyton Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
resumo patente de invenção: "agente antifúngico tópico". a presente invenção refere-se a um agente anti-trichophyton que compreende, como ingrediente ativo, um composto tendo a estrutura de 2-(1h-pirazol-1-il)fenol representada pela fórmula (i) ou (ii) a seguir, ou um sal do mesmo. fórmula química 8
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011-017347 | 2011-01-30 | ||
| JP2011017347 | 2011-01-30 | ||
| PCT/JP2012/051991 WO2012102404A1 (ja) | 2011-01-30 | 2012-01-30 | 外用抗真菌剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112013018938A2 true BR112013018938A2 (pt) | 2017-10-17 |
| BR112013018938A8 BR112013018938A8 (pt) | 2018-01-09 |
| BR112013018938B1 BR112013018938B1 (pt) | 2019-10-08 |
Family
ID=46580967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013018938-0A BR112013018938B1 (pt) | 2011-01-30 | 2012-01-30 | Composto antifúngico tópico, agente antifúngico para tinha e agente antifúngico para tinha das unhas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8889727B2 (pt) |
| EP (1) | EP2669274B1 (pt) |
| JP (1) | JP5362128B2 (pt) |
| KR (1) | KR101463707B1 (pt) |
| CN (1) | CN103339112B (pt) |
| AR (1) | AR084948A1 (pt) |
| AU (1) | AU2012209696B2 (pt) |
| BR (1) | BR112013018938B1 (pt) |
| CA (1) | CA2825889C (pt) |
| CL (1) | CL2013001995A1 (pt) |
| CO (1) | CO6741178A2 (pt) |
| DK (1) | DK2669274T3 (pt) |
| ES (1) | ES2560930T3 (pt) |
| HK (1) | HK1190713A1 (pt) |
| IL (1) | IL227705A (pt) |
| MX (1) | MX2013008777A (pt) |
| MY (1) | MY161280A (pt) |
| PH (1) | PH12013501606A1 (pt) |
| RU (1) | RU2593990C2 (pt) |
| SG (1) | SG192582A1 (pt) |
| TW (1) | TWI491593B (pt) |
| UA (1) | UA110816C2 (pt) |
| WO (1) | WO2012102404A1 (pt) |
| ZA (1) | ZA201305718B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014021282A1 (ja) * | 2012-07-30 | 2014-02-06 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 抗白癬菌症外用液剤 |
| WO2014021284A1 (ja) * | 2012-07-30 | 2014-02-06 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 抗白癬菌症貼付剤 |
| US8805865B2 (en) | 2012-10-15 | 2014-08-12 | Juked, Inc. | Efficient matching of data |
| WO2014111871A1 (en) | 2013-01-17 | 2014-07-24 | Aurigene Discovery Technologies Limited | 4,5-dihydroisoxazole derivatives as nampt inhibitors |
| KR102137861B1 (ko) * | 2014-08-13 | 2020-07-24 | 메이지 세이카 파루마 가부시키가이샤 | 결정성 항백선균약 및 그 제조 방법 |
| US11534483B2 (en) | 2016-03-15 | 2022-12-27 | Igor Polyakov | Compositions for the treatment and prevention of hoof and claw diseases |
| BR112020008282A2 (pt) | 2017-10-30 | 2020-10-20 | Kaken Pharmaceutical Co., Ltd. | preparação externa para tratar trichophytosis unguium |
| CN110862349B (zh) * | 2019-11-11 | 2023-05-05 | 南京医科大学 | 依达拉奉类似物及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3628892A1 (de) * | 1986-08-26 | 1988-03-10 | Bayer Ag | Substituierte 1-aryl-3-tert.-butyl-pyrazole |
| ES2015648A6 (es) | 1989-05-05 | 1990-09-01 | Consejo Superior Investigacion | Procedeimiento de sintesis de mono y bis (3-r3-4-r4-5-r5-pirazol-1-il)1,4-dihidroxibencenos. |
| TW297813B (pt) * | 1993-09-24 | 1997-02-11 | Takeda Pharm Industry Co Ltd | |
| DE4414897A1 (de) | 1994-04-28 | 1995-11-02 | Hoechst Ag | Aromatische Diazoniumsalze und deren Verwendung in strahlungsempfindlichen Gemischen |
| JP3729884B2 (ja) | 1995-01-05 | 2005-12-21 | 関東電化工業株式会社 | フルオロフェノール類の製造方法 |
| JPH1160528A (ja) | 1997-08-12 | 1999-03-02 | Ube Ind Ltd | ４−クロロ−３−トリフルオロメチルフェノールの製法 |
| AU2827100A (en) | 2000-03-03 | 2001-09-17 | Sumitomo Chemical Company, Limited | Process for the preparation of phenylhydrazines |
| US6916814B2 (en) | 2001-07-11 | 2005-07-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods of treating cytokine mediated diseases |
| AU2003271117A1 (en) * | 2002-10-09 | 2004-05-04 | Ssp Co., Ltd. | Novel pyrazole compounds having antifungal activity |
| KR100509603B1 (ko) | 2002-12-28 | 2005-08-22 | 삼성에스디아이 주식회사 | 적색 발광 화합물 및 이를 채용한 유기 전계 발광 소자 |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| WO2007083320A2 (en) | 2006-01-19 | 2007-07-26 | Matrix Laboratories Ltd | Conversion of aromatic diazonium salt to aryl hydrazine |
| US20080119457A1 (en) * | 2006-08-24 | 2008-05-22 | Serenex, Inc. | Benzene, Pyridine, and Pyridazine Derivatives |
-
2012
- 2012-01-30 PH PH1/2013/501606A patent/PH12013501606A1/en unknown
- 2012-01-30 CN CN201280006728.4A patent/CN103339112B/zh not_active Expired - Fee Related
- 2012-01-30 BR BR112013018938-0A patent/BR112013018938B1/pt not_active IP Right Cessation
- 2012-01-30 RU RU2013140163/04A patent/RU2593990C2/ru not_active IP Right Cessation
- 2012-01-30 SG SG2013057690A patent/SG192582A1/en unknown
- 2012-01-30 AR ARP120100287A patent/AR084948A1/es unknown
- 2012-01-30 TW TW101102991A patent/TWI491593B/zh not_active IP Right Cessation
- 2012-01-30 EP EP12739689.3A patent/EP2669274B1/en not_active Not-in-force
- 2012-01-30 JP JP2012554877A patent/JP5362128B2/ja not_active Expired - Fee Related
- 2012-01-30 UA UAA201310519A patent/UA110816C2/uk unknown
- 2012-01-30 WO PCT/JP2012/051991 patent/WO2012102404A1/ja active Application Filing
- 2012-01-30 CA CA2825889A patent/CA2825889C/en not_active Expired - Fee Related
- 2012-01-30 MY MYPI2013701321A patent/MY161280A/en unknown
- 2012-01-30 KR KR1020137022868A patent/KR101463707B1/ko active IP Right Grant
- 2012-01-30 MX MX2013008777A patent/MX2013008777A/es active IP Right Grant
- 2012-01-30 DK DK12739689.3T patent/DK2669274T3/en active
- 2012-01-30 US US13/982,734 patent/US8889727B2/en not_active Expired - Fee Related
- 2012-01-30 ES ES12739689.3T patent/ES2560930T3/es active Active
- 2012-01-30 AU AU2012209696A patent/AU2012209696B2/en not_active Ceased
-
2013
- 2013-06-21 CO CO13148029A patent/CO6741178A2/es unknown
- 2013-07-08 CL CL2013001995A patent/CL2013001995A1/es unknown
- 2013-07-29 ZA ZA2013/05718A patent/ZA201305718B/en unknown
- 2013-07-29 IL IL227705A patent/IL227705A/en active IP Right Grant
-
2014
- 2014-04-22 HK HK14103829.5A patent/HK1190713A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013018938A2 (pt) | agente antifúngico tópico | |
| EA201500386A1 (ru) | Пестицидные смеси, содержащие жасмоновую кислоту или её производное | |
| BR112013025732A2 (pt) | composto de imidazo-oxazina ou sal do mesmo | |
| BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
| CO7200281A2 (es) | Composicion para control de enfermedades de plantas y aplicacion para la misma | |
| BR112015032921A8 (pt) | compostos de benzofuranila e benzoxazolila substituídos e utilizações dos mesmos | |
| BR112015018966A2 (pt) | composição de controle de pestes e uso da mesma | |
| BR112015018738A8 (pt) | compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica | |
| MX2020001453A (es) | Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos. | |
| BR112013021337A2 (pt) | agente de controle de endoparasita e método para controlar endoparasitas | |
| BR112013020270A2 (pt) | derivados de pirazol microbicidas | |
| BR112012027373A2 (pt) | composição pesticida e seu uso | |
| EA201270216A1 (ru) | Фармацевтический состав | |
| BR112014000178A2 (pt) | composições tópicas | |
| BR112015009806A2 (pt) | composições adjuvantes aquosas | |
| UA107709C2 (en) | Microencapsulated oils for controlling pesticide spray drift | |
| CO7180223A2 (es) | Composición herbicida que tiene actividad herbicida mejorada | |
| BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
| BR112015024075A2 (pt) | compostos de piridinilpirazoloquinolina | |
| BR112012011002A2 (pt) | derivado de 1-heterodieno e agente de controle de pragas | |
| BR112014026198A2 (pt) | compostos pirazol como inibidores de sglt1 | |
| BR112014007078A2 (pt) | composição de controle de doença de plantas e seu uso | |
| BR112013028598A2 (pt) | método para promover o crescimento de plantas | |
| BR112013020419A2 (pt) | microbicidas derivados de pirazol | |
| BR112012021674A2 (pt) | composição de controle de doença de planta e método para controlar doença de planta. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/01/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/01/2012, OBSERVADAS AS CONDICOES LEGAIS |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2655 DE 23-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |